doc.ai and UCB Biopharma Team Up to Develop Breakthrough Artificial Intelligence Models to Advance Care

PALO ALTO, Calif.--(BUSINESS WIRE)--doc.ai, an enterprise AI platform accelerating digital transformation in healthcare, and UCB, a multinational biopharma company headquartered in Brussels, Belgium, today announced a new collaboration in AI medical research with the launch of a digital health trial for myasthenia gravis, a neuromuscular disease that can lead to impaired speech, blurred vision, difficulty swallowing, and other symptoms. The trailblazing research will use smartphones to detect v

Click to view original post